Eliem Therapeutics, Inc. Profile Avatar - Palmy Investing

Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central ner…

Biotechnology
US, Redmond [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Eliem Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Eliem Therapeutics, Inc. has no acquisition track records yet.

End of ELYM's Analysis
CIK: 1768446 CUSIP: 28658R106 ISIN: US28658R1068 LEI: - UEI: -
Secondary Listings
ELYM has no secondary listings inside our databases.